Flexion has also granted the underwriters a 30-day option to purchase up to an additional 756,000 shares of common stock. BMO Capital Markets and RBC Capital Markets are acting as joint book-running managers.
Flexion Therapeutics is clinical-stage specialty pharmaceutical company focused on the development and commercialization of pain therapies.
More articles on anesthesia:
17 Lincoln Anesthesiology Group providers join The Physician Network
MEDNAX begins $200M accelerated share repurchase
NAPA to provide exclusive anesthesia services at Southington Surgery Center
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
